Phase II study of a pandemic influenza vaccine [influenza A virus vaccine-H5N1] in elderly participants.
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Sponsors CSL
- 18 Jan 2007 Status change from recruiting to completed.
- 04 Nov 2006 New trial record.